Sprout Pharmaceuticals

Sprout Pharmaceuticals

Sprout Pharmaceuticals

Sprout Pharmaceuticals develops products for the treatment of female sexual dysfunction.
Founded
2011
Raised
$4.3M
Follow us
Alexa global traffic share
Acquired by
Valeant Pharmaceuticals
20 Aug 2015
$1,000,000,000
Latest funding
$4,303,856
Venture capital - 2014

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Sprout Pharmaceuticals makes some noise.